Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.80 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.77 |
| ▸ | SIGMAR1 | Q99720 | 5/20 | 0.69 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.61 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.56 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.56 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.56 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.56 |
| ▸ | NCOR2 | Q9Y618 | 2/20 | 0.56 |
| ▸ | MC4R | P32245 | 1/20 | 0.54 |
| ▸ | MC5R | P33032 | 1/20 | 0.54 |
| ▸ | MC3R | P41968 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | ACHE | P22303 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21799782 | 1.00 | MAOA (0.80) | MAOACHRM2SIGMAR1MEN1KMT2A | |
| SCHEMBL21799882 | 1.00 | MAOA (0.80) | MAOACHRM2SIGMAR1MEN1KMT2A | |
| SCHEMBL8499135 | 1.00 | MAOA (0.80) | MAOACHRM2SIGMAR1MEN1KMT2A | |
| SCHEMBL9766684 | 1.00 | MAOA (0.80) | MAOACHRM2SIGMAR1MEN1KMT2A | |
| SCHEMBL7804948 | 1.00 | MAOA (0.80) | MAOACHRM2SIGMAR1MEN1KMT2A | |
| SCHEMBL21800068 | 1.00 | MAOA (0.80) | MAOACHRM2SIGMAR1MEN1KMT2A | |
| SCHEMBL21799465 | 1.00 | MAOA (0.80) | MAOACHRM2SIGMAR1MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL29778288 | 0.98 | MAOA (0.77) | MAOACHRM2SIGMAR1MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL29778282 | 0.98 | MAOA (0.77) | MAOACHRM2SIGMAR1MEN1KMT2A | |
| SCHEMBL8643581 | 0.98 | CHRM2 (0.81) | MAOACHRM2SIGMAR1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4240799-B1 | SOIL PROTECTION SYSTEM WITH HIGH DYNAMIC CRACK BRIDGING | SIKA TECH AG (CH) | 2025-01-08 | — | — | EP | disclosed |
| EP-3623398-B1 | RESIN COMPOSITION COMPRISING A MODIFIED BLOCK COPOLYMER AND METHOD FOR PRODUCING MODIFIED BLOCK COPOLYMER | ASAHI CHEMICAL IND (JP) | 2024-08-28 | — | — | EP | disclosed |
| US-20230312975-A1 | FLOOR PROTECTION SYSTEM WITH HIGH DYNAMIC CRACK BRIDGING | SIKA TECHNOLOGY AG (CH) | 2023-10-05 | — | — | US | disclosed |
| EP-4240799-A1 | FLOOR PROTECTION SYSTEM WITH HIGH DYNAMIC CRACK BRIDGING | Sika Technology AG (CH) | 2023-09-13 | — | — | EP | disclosed |
| CN-116472318-A | Ground protection system with high dynamic fracture bridging | SIKA技术股份公司 | 2023-07-21 | — | — | CN | disclosed |
| CN-110312748-B | Curing agents for low emission epoxy resin compositions | SIKA技术股份公司 | 2023-01-06 | — | — | CN | disclosed |
| CN-110603273-B | Modified block copolymer, method for producing modified block copolymer, and resin composition | 旭化成株式会社 | 2022-10-14 | — | — | CN | disclosed |
| WO-2022096707-A1 | FLOOR PROTECTION SYSTEM WITH HIGH DYNAMIC CRACK BRIDGING | SIKA TECHNOLOGY AG (CH) | 2022-05-12 | — | — | WO | disclosed |
| EP-3995549-A1 | SOIL PROTECTION SYSTEM WITH HIGH DYNAMIC CRACK BRIDGING | Sika Technology AG (CH) | 2022-05-11 | — | — | EP | disclosed |
| US-11124593-B2 | Modified block copolymer, method for producing modified block copolymer, and resin composition | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2021-09-21 | — | — | US | disclosed |
| US-20020164671-A1 | Electrochemical saccharide sensor | BAXTER INTERNATIONAL INC. | 2002-11-07 | — | — | US | disclosed |
| WO-2002072588-A2 | PHOTO-INDUCED ELECTRON TRANSFER FLUORESCENT SENSOR MOLECULES | BECKMAN COULTER, INC. (US) | 2002-09-19 | — | — | WO | disclosed |
| US-20020119581-A1 | Detection of analytes | SENSORS FOR MEDICINE AND SCIENCE, INC. | 2002-08-29 | — | — | US | disclosed |
| US-20020115096-A1 | Photo-induced electron transfer fluorescent sensor molecules | BECKMAN COULTER, INC. | 2002-08-22 | — | — | US | disclosed |
| US-20020094586-A1 | Detection of analytes | SENSORS FOR MEDICINE AND SCIENCE, INC. (US) | 2002-07-18 | — | — | US | disclosed |
| WO-2002054067-A2 | DETECTION OF ANALYTES | SENSORS FOR MEDICINE AND SCIENCE, INC. (US) | 2002-07-11 | — | — | WO | disclosed |
| US-6387672-B1 | MODULAR FLUORESCENCE SENSOR FOR DETECTION OF SACCHARIDES | BECKMAN COULTER, INC. | 2002-05-14 | — | — | US | disclosed |
| US-5847092-A | Erythromycin A 9-0 oxime derivatives endowed with antibiotic activity | ZAMBON GROUP S.P.A. (IT) | 1998-12-08 | — | — | US | disclosed |
| EP-0056115-A2 | Moulding masses stabilized against thermolysis and containing a very small quantity of monomer | BAYER AG (DE) | 1982-07-21 | — | — | EP | disclosed |
| US-4093674-A | THERMOSETTING RESIN AND A POLYISOCYANATE | NIPPON PAINT CO., LTD. (JA) | 1978-06-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020115096-A1 | Photo-induced electron transfer fluorescent sensor molecules | AFF1, YBX1, AFF2 | MAOA 1718/4885CHRM2 259/4885SIGMAR1 978/4885 |
| US-20020094586-A1 | Detection of analytes | AKR7A2, DDX6, ANXA6 | MAOA 1212/4885CHRM2 3389/4885SIGMAR1 3839/4885 |
| US-20020164671-A1 | Electrochemical saccharide sensor | BTD, SLC2A8, SLC5A2 | MAOA 1054/4885CHRM2 1634/4885SIGMAR1 3693/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.